✦ LIBER ✦

Low-dose prophylactic intravenous immunoglobulin does not prevent HLA allosensitization in LVAD recipients

✍ Scribed by S.G Drakos; J.W Long; J.C Stringham; T.C Fuller; B.A Campbell; S.S Schmitz; K.E Nelson; S.A Moore; E.M Gilbert; D.G Renlund

Book ID: 116517945
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 69 KB
Volume: 23
Category: Article
ISSN: 1557-3117
DOI: 10.1016/j.healun.2003.11.309

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Low-Dose Prophylactic Intravenous Immuno

Low-Dose Prophylactic Intravenous Immunoglobulin Does Not Prevent HLA Sensitization in Left Ventricular Assist Device Recipients

✍ Stavros G. Drakos; Abdallah G. Kfoury; James W. Long; James C. Stringham; Thomas 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Avoidance of cellular blood product tran

Avoidance of cellular blood product transfusions in LVAD recipients does not prevent HLA allosensitization

✍ James C Stringham; David A Bull; Thomas C Fuller; Abdallah G Kfoury; David O Tay 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 277 KB

Low-dose aspirin therapy is associated w

Low-dose aspirin therapy is associated with few side effects but does not prevent hepatic artery thrombosis in liver transplant recipients

✍ Wolf, D C ;Freni, M A ;Boccagni, P ;Mor, E ;Chodoff, L ;Birnbaum, A ;Miller, C M 📂 Article 📅 1997 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 84 KB 👁 1 views

Hepatic artery thrombosis occurs in 4% to 10% of adult patients and in up to 26% of children undergoing liver transplantation. Aspirin has been used to prevent this complication but may increase procedure-related and gastrointestinal bleeding. The aim of this study was to assess the efficacy and saf